In a startling pandemic preparedness development, Moderna yesterday announced that US Department of Health and Human Services ...

Neutralizing antibodies tested 90 days after infection were greater in participants who had been vaccinated before their ...

The US Centers for Disease Control and Prevention (CDC) in its weekly update today reported 42 measles cases, some tied to a ...

Though measles activity continues to decline in a large outbreak centered in West Texas, other states continue to report a ...

Surveillance identified 7,381 candidemia cases, with an incidence of 7.4 cases per 100,000 people. Across age-groups, sexes, ...

Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral ...

The 19 low- and middle-income countries experienced 28,000 congenital rubella syndrome cases—78% of the world's cases—in 2023 ...

The data show a continuation of a decades-old trend toward increasing US excess deaths, mainly among working-age adults, ...

Cambodia's ministry of health has reported its fourth fatal human H5N1 avian flu case of the year, which involves an ...

The CDC is still recommending COVID vaccination for children ages 6 months to 17 years who are moderately or severely ...

Today vaccine maker Moderna announced it voluntarily pulled its licensing submission for the combination seasonal ...

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...